These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33337999)

  • 21. New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.
    Leclair V; Lundberg IE
    Curr Rheumatol Rep; 2018 Mar; 20(4):18. PubMed ID: 29550929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus.
    Rodrigues Fonseca A; Felix Rodrigues MC; Sztajnbok FR; Gerardin Poirot Land M; Knupp Feitosa de Oliveira S
    Adv Rheumatol; 2019 May; 59(1):20. PubMed ID: 31092290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of ENMC and EULAR/ACR classification systems applied to a single tertiary center cohort of dermatomyositis patients.
    Zoske J; Schneider U; Siegert E; Kleefeld F; Preuße C; Stenzel W; Hahn K
    Neurol Res Pract; 2021 Nov; 3(1):59. PubMed ID: 34776008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of the 2017 ACR/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: Role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies.
    Sánchez-Mendieta GG; Vega-Morales D; Villarreal-Alarcón MÁ; Compean-Villegas JE; Moreno-Arquieta IA; Galarza-Delgado DÁ
    Reumatol Clin (Engl Ed); 2024 Mar; 20(3):142-146. PubMed ID: 38494305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
    Saygin D; Glaubitz S; Zeng R; Bottai M; de Visser M; Dimachkie MM; Fiorentino D; Gerhardson I; Kuwana M; Miller FW; Needham M; Rider LG; Salem Y; Schlüter S; Shinjo SK; Wang G; Werth VP; Aggarwal R; Lundberg IE
    Clin Exp Rheumatol; 2024 Feb; 42(2):403-412. PubMed ID: 38436279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in a paediatric population-a multicentre study.
    Levinsky Y; Broide M; Kagan S; Goldberg O; Scheuerman O; Tal R; Tirosh I; Butbul Y; Furst DE; Harel L; Amarilyo G
    Rheumatology (Oxford); 2021 Nov; 60(11):5142-5148. PubMed ID: 33560345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma.
    Araújo FC; Camargo CZ; Kayser C
    Rheumatol Int; 2017 Nov; 37(11):1825-1833. PubMed ID: 28819792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile dermatomyositis: a tertiary center experience.
    Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
    Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Juvenile idiopathic inflammatory myopathies: A clinicopathological study with emphasis on muscle histology.
    Challa S; Hui M; Jakati S; Uppin MS; Rajasekhar L; Kannan MA; Lingappa L; Jagarlapudi MMK
    Indian J Pathol Microbiol; 2019; 62(1):61-66. PubMed ID: 30706861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment.
    Adamichou C; Nikolopoulos D; Genitsaridi I; Bortoluzzi A; Fanouriakis A; Papastefanakis E; Kalogiannaki E; Gergianaki I; Sidiropoulos P; Boumpas DT; Bertsias GK
    Ann Rheum Dis; 2020 Feb; 79(2):232-241. PubMed ID: 31704720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
    Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
    Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus.
    Batu ED; Akca UK; Kısaarslan AP; Sağ E; Demir F; Demir S; Çiçek SÖ; Poyrazoglu H; Sozeri B; Bilginer Y; Ozen S
    J Rheumatol; 2021 Jun; 48(6):907-914. PubMed ID: 33191281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the ACR-EULAR criteria for primary Sjögren's syndrome in a Dutch prospective diagnostic cohort.
    van Nimwegen JF; van Ginkel MS; Arends S; Haacke EA; van der Vegt B; Sillevis Smitt-Kamminga N; Spijkervet FKL; Kroese FGM; Stel AJ; Brouwer E; Vissink A; Bootsma H
    Rheumatology (Oxford); 2018 May; 57(5):818-825. PubMed ID: 29444331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
    Lazarevic D; Pistorio A; Palmisani E; Miettunen P; Ravelli A; Pilkington C; Wulffraat NM; Malattia C; Garay SM; Hofer M; Quartier P; Dolezalova P; Penades IC; Ferriani VP; Ganser G; Kasapcopur O; Melo-Gomes JA; Reed AM; Wierzbowska M; Rider LG; Martini A; Ruperto N;
    Ann Rheum Dis; 2013 May; 72(5):686-93. PubMed ID: 22736096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to: 'External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies' by Luu
    Jinnin M; Ohta A; Kohsaka H
    Ann Rheum Dis; 2022 Apr; 81(4):e60. PubMed ID: 32398284
    [No Abstract]   [Full Text] [Related]  

  • 37. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.
    Bottai M; Tjärnlund A; Santoni G; Werth VP; Pilkington C; de Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Danko K; Dimachkie MM; Feldman BM; García-De La Torre I; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinka M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Wook Song Y; Vencovsky J; Ytterberg SR; Miller FW; Rider LG; Lundberg IE;
    RMD Open; 2017; 3(2):e000507. PubMed ID: 29177080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and disease course of patients with juvenile dermatomyositis.
    Gowdie PJ; Allen RC; Kornberg AJ; Akikusa JD
    Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus in a multiethnic Malaysian cohort.
    Selvananda S; Kan SL
    Int J Rheum Dis; 2022 Feb; 25(2):131-139. PubMed ID: 34939743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe rhabdomyolysis due to idiopathic inflammatory myopathies, a wary manifestation of a heterogenous pathology.
    Schepens N; Herroelen PH; Decavele AS; Vanacker A
    Acta Clin Belg; 2023 Apr; 78(2):160-164. PubMed ID: 35491881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.